417 results on '"Capecchi, PIER LEOPOLDO"'
Search Results
2. Life-Threatening Arrhythmias in Patients With Takotsubo Syndrome: Insights Into Pathophysiology and Treatment Innovations
3. Worldwide Survey of COVID-19–Associated Arrhythmias
4. Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults
5. Fir(e)ing the Rhythm: Inflammatory Cytokines and Cardiac Arrhythmias
6. Increased interleukin‐6 levels are associated with atrioventricular conduction delay in severe COVID‐19 patients.
7. Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
8. The Role of Inflammation and Autoimmunity in Long QT Syndrome
9. Pathogenesis of Autoimmune-Associated Long QT Syndrome
10. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19
11. Contributors
12. Emerging risk factors for QT interval prolongation and torsades de pointes
13. Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine
14. Elevated Interleukin‐6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans
15. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids
16. Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms
17. Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment
18. Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans
19. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression
20. The Role of Inflammation and Autoimmunity in Long QT Syndrome
21. Pathogenesis of Autoimmune-Associated Long QT Syndrome
22. Letter by Lazzerini et al Regarding Article, “Autoantibody Signature in Cardiac Arrest”
23. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!
24. Reply
25. Lower frequency of SARS-CoV-2-associated severe respiratory infections among adults vaccinated against the 2021/22 season influenza
26. Contribution of cytokine-mediated prolongation of QTc interval to the multi-hit theory of Torsade de Pointes
27. Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome
28. Surveillance of Influenza and Other Airborne Transmission Viruses during the 2021/2022 Season in Hospitalized Subjects in Tuscany, Italy
29. Fir(e)ing the Rhythm
30. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: An in-vitro study in healthy humans
31. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study
32. Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad
33. Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the ‘dark side of the immune’
34. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation
35. REPLY: Autoimmune cardiac channelopathies: the heart of the matter
36. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies
37. Editorial: Insights in General Cardiovascular Medicine: 2021
38. Anti-Ca v 1.2 Antibody–Induced Atrioventricular Block as a Novel Form in the Adult: Long-Term Pacemaker-Sparing Activity of Hydroxychloroquine
39. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis
40. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells
41. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes
42. CORRIGENDUM: Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias
43. Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias
44. The role of P2X7 receptors in tissue fibrosis: a brief review
45. One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies
46. Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation
47. Chapter 6 - Emerging risk factors for QT interval prolongation and torsades de pointes
48. Statins and the Joint: Multiple Targets for a Global Protection?
49. Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
50. Homocysteine and Raynaud's phenomenon: A review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.